CMPX
Price
$1.42
Change
-$0.11 (-7.19%)
Updated
Dec 18, 04:59 PM (EDT)
91 days until earnings call
INVA
Price
$17.92
Change
-$0.45 (-2.45%)
Updated
Dec 18, 04:59 PM (EDT)
49 days until earnings call
Ad is loading...

CMPX vs INVA

Header iconCMPX vs INVA Comparison
Open Charts CMPX vs INVABanner chart's image
Compass Therapeutics
Price$1.42
Change-$0.11 (-7.19%)
Volume$2.1K
CapitalizationN/A
Innoviva
Price$17.92
Change-$0.45 (-2.45%)
Volume$29.25K
CapitalizationN/A
CMPX vs INVA Comparison Chart
Loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMPX vs. INVA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMPX is a Hold and INVA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (CMPX: $1.53 vs. INVA: $18.37)
Brand notoriety: CMPX and INVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMPX: 47% vs. INVA: 97%
Market capitalization -- CMPX: $210.51M vs. INVA: $1.15B
CMPX [@Biotechnology] is valued at $210.51M. INVA’s [@Biotechnology] market capitalization is $1.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMPX’s FA Score shows that 0 FA rating(s) are green whileINVA’s FA Score has 0 green FA rating(s).

  • CMPX’s FA Score: 0 green, 5 red.
  • INVA’s FA Score: 0 green, 5 red.
According to our system of comparison, INVA is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMPX’s TA Score shows that 3 TA indicator(s) are bullish while INVA’s TA Score has 4 bullish TA indicator(s).

  • CMPX’s TA Score: 3 bullish, 7 bearish.
  • INVA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INVA is a better buy in the short-term than CMPX.

Price Growth

CMPX (@Biotechnology) experienced а -14.04% price change this week, while INVA (@Biotechnology) price change was -3.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

CMPX is expected to report earnings on Mar 19, 2025.

INVA is expected to report earnings on Feb 05, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INVA($1.15B) has a higher market cap than CMPX($211M). INVA YTD gains are higher at: 14.526 vs. CMPX (-1.923).
CMPXINVACMPX / INVA
Capitalization211M1.15B18%
EBITDAN/AN/A-
Gain YTD-1.92314.526-13%
P/E RatioN/A22.96-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A449M-
FUNDAMENTALS RATINGS
INVA: Fundamental Ratings
INVA
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
35
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMPXINVA
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 10 days ago
69%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 2 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
60%
View a ticker or compare two or three
Ad is loading...
CMPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with TRDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+2.68%
TRDA - CMPX
43%
Loosely correlated
+2.44%
ABCL - CMPX
41%
Loosely correlated
-2.45%
ABOS - CMPX
41%
Loosely correlated
-0.51%
FHTX - CMPX
41%
Loosely correlated
N/A
XNCR - CMPX
39%
Loosely correlated
+2.12%
More

INVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, INVA has been loosely correlated with TECH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if INVA jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INVA
1D Price
Change %
INVA100%
-0.27%
TECH - INVA
38%
Loosely correlated
-1.17%
REGN - INVA
34%
Loosely correlated
+2.09%
CRSP - INVA
34%
Loosely correlated
+0.88%
CMPX - INVA
34%
Loosely correlated
+2.68%
NTLA - INVA
34%
Loosely correlated
-1.87%
More